The drug is delivered through using the company’s DepoFoam technology and extends the duration of the analgesia. In clinical trials, the drug provided pain relief for up to 72 hours compared with the analgesic’s normal time of less than seven hours.
Related Articles on Pain Management:
Study: Lower Dose of Corticosteroids Just as Effective as Higher for Shoulder Pain
Pain Makes Patients More Self-Absorbed
Nanoparticles May Improve Arthritis Pain Treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.